Additional financial costs borne by cancer patients: A narrative review

European Journal of Oncology Nursing

Volumn 15, Issue 4, 2011, Pages 302-310

  Brooks, Joanna ^a   Wilson, Kate ^b   Amir, Ziv ^b  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Carer; Economic hardship; Family; Hidden costs; Out of pocket expenses

Indexed keywords

ARTICLE; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; NEOPLASM; UNITED KINGDOM; VERBAL COMMUNICATION;

COST OF ILLNESS; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH; NARRATION; NEOPLASMS;

EID: 79961028401     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2010.10.005     Document Type: Article

References (42)

1. Amir Z., Neary D., Luker K. Cancer survivors' views of work 3 years post diagnosis: a UK perspective. European Journal of Oncology Nursing 2008, 2:190-197.
2. Amir Z., Moran T., Walsh L., Iddenden R., Luker K. Return to paid work after cancer: a British experience. Journal of Cancer Survivorship 2007, 1:129-136.
3. Baldwin L., Cai Y., Larson E.H., Dobie S.A., Wright G.E., Goodman D.C., Matthews B., Hart L.G. Access to cancer services for rural colorectal patients. Journal of Rural Health 2008, 24:390-394.
4. Ballatori G., Roila F., Ruggeri B., Porrozzi S., Iannopollo M., Soru G., Cruciani G., Daniele B., Locatelli M.C., Pellissier J., Deuson R. The cost of chemotherapy-induced nausea and vomiting in Italy. Supportive Care in Cancer 2007, 15:31-38.
5. Beaver K., Hollingworth W., McDonald R., Dunn G., Tyser-Robinson D., Thomson L., Hindley A.C., Susnerwala S.S., Luker K. Economic evaluation of a randomized clinical trial of hospital versus telephone follow-up after treatment for breast cancer. British Journal of Surgery 2009, 96:1406-1415.
6. Bradley S., Sherwood P.R., Donovan H.S., Hamilton R., Rosensweig M., Hricik A., Newberry A., Bender C. I could lose everything: understanding the cost of a brain tumor. Journal of Neuro-Oncology 2007, 85:329-338.
7. Brown M.L. Special report - the national economic burden of cancer: an update. Journal of the National Cancer Institute 1990, 82:1811-1814.
8. Cohn R.J., Goodenough B., Foreman T., Suneson J. Hidden financial costs in treatment for childhood cancer: an Australian study of lifestyle implications for families absorbing out-of-pocket expenses. Journal of Pediatric Hematology Oncology 2003, 25:854-863.
9. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine 2000, 160:2101-2107.
10. Dixon-Woods M., Agarwal S., Jones D., Young B., Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. Journal of Health Services Research & Policy 2005, 10(1):45-53.
11. DuPont R.L., Rice D.P., Miller L.S., Shiraki S.S., Rowland C.R., Harwood H.J. Economic costs of anxiety disorders. Anxiety 1996, 2:167-172.
12. Eiser C., Upton P. Costs of caring for a child with cancer: a questionnaire study. Child Care Health and Development 2006, 33:455-459.
13. Ell K., Xie B., Wells A., Nedjat-Haiem F., Lee P.J., Vourlekis B. Economic stress among low-income women with cancer: effects on quality of life. Cancer 2008, 112:616-625.
14. Fortner B.V., Tauer K., Zhu L., Okon T.A., Moore K., Templeton D., Schwartzberg L. Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities. BMC Cancer 2004, http://www.biomedcentral.com/1471-2407/4/22.
15. Fortner B.V., Demarco G., Irving G., Ashley J., Keppler G., Chavez J., Munk J. Description and predictors of direct and indirect costs of pain reported by cancer patients. Journal of Pain and Symptom Management 2003, 25:9-18.
16. Frey P., Stinson A., Knight S., Ferdman E., Traynor A., O'Gara K., Rademaker A., Bennett C., Winter J.N. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplantation 2002, 30:741-748.
17. Gallagher P., Buckmaster A., O'Carroll S., Kiernan G., Geraghty J. Experiences in the provision, fitting and supply of external breast prostheses: findings from a national survey. European Journal of Cancer Care 2009, 18:556-568.
18. Gordon L., Scuffham P., Hayes S., Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho-Oncology 2007, 16:1130-1139.
19. Grunfeld E., Gray A., Mant D., Yudkin P., Adewuyi-Dalton R., Coyle D., Cole D., Stewart J., Fitzpatrick R., Vessey M. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. British Journal of Cancer 1999, 79:1227-1233.
20. Hanratty B., Holland P., Jacoby A., Whitehead M. Financial stress and strain associated with terminal cancer - a review of the evidence. Palliative Medicine 2007, 21:595-607.
21. Heath J.A., Lintuuran M., Rigguto G., Tikotlian N., McCarthy M. Childhood cancer: its impact and financial costs for Australian families. Pediatric Hematology and Oncology 2006, 23:439-448.
22. Hopper C., Niziol C., Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncology 2004, 40:372-382.
23. Langa K.M., Fendrick A.M., Chernew M.E., Kabeto M.U., Paisley K.L., Hayman J.A. Out-of-pocket health-care expenditures among older Americans with cancer. Value in Health 2004, 7:186-194.
24. Lauzier S., Maunsell E., Drolet M., Coyle D., Hebert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers. Quality of Life Research 2010, 19:177-189.
25. Lauzier S., Maunsell E., de Koninck M., Drolet M., Hebert-Croteau N., Robert J. Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psycho-Oncology 2005, 14:351-360.
26. Longo C.J., Deber R., Fitch M., Williams A.P., D'Souza D. An examination of cancer patients' monthly 'out-of-pocket' costs in Ontario, Canada. European Journal of Cancer Care 2007, 16:500-507.
27. Longo C.J., Fitch M., Deber R.B., Williams A.P. Financial and family burden associated with treatment in Ontario, Canada. Supportive Care in Cancer 2006, 14:1077-1085.
28. Macmillan Cancer Support Cancer costs: the hidden price of getting treatment Available at. http://www.macmillan.org.uk/Documents/GetInvolved/Campaigns/Campaigns/Cancercosts.pdf.
29. Mathews M., Buehler S., West R. Perceptions of healthcare providers concerning patient and health care provider strategies to limit out-of pocket costs for cancer care. Current Oncology 2009, 16:3-8.
30. Meropol N.J., Schulman K.A. Costs of cancer care: issues and implications. Journal of Clinical Oncology 2007, 25:180-186. 2, January 10.
31. Miedema B., Easley J., Fortin P., Hamilton R., Mathews M. The economic impact on families when a child is diagnosed with cancer. Current Oncology 2008, 15:8-13.
32. Moore K.A. Breast cancer patients' out-of-pocket expenses. Cancer Nursing 1999, 22:389-396.
33. Morris S., Cox B., Bosanquet N. Cost of skin cancer in England. European Journal of Health Economics 2009, 10:267-273.
34. ®: a standard cost model for breast-cancer treatment in a Belgian university hospital. International Journal of Technology Assessment in Health Care 2005, 21:132-137.
35. Office for National Statistics Cancer statistics registrations: registrations of cancer diagnosed in 2006 2008, HMSO, England. London. http://www.statistics.gov.uk/cci/nugget.asp?id%3D915.
36. Pearce S., Kelly D., Stevens W. 'More than just money' - widening the understanding of the costs involved in cancer care. Journal of Advanced Nursing 2008, 33:371-379.
37. Renehan A.G., O'Dwyer S., Whynes D.K. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. British Medical Journal 2004, 328:81-85.
38. Scott J.A., Kearney N., Hummerston S., Molassiotis A. Use of complementary and alternative medicine in patients with cancer: a UK survey. European Journal of Oncology Nursing 2005, 9:131-137.
39. Sculpher M., Palmer M., Heyes A. Costs incurred by patients undergoing advanced colorectal cancer therapy: a comparison of raltitrexed and fluorouracil plus folinic acid. Pharmacoeconomics 2000, 17:361-370.
40. Secco G.B., Fardelli R., Gianquinto D., Bonfante P., Baldi E., Ravera G., Derchi L., Ferraris R. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomised and controlled trial. European Journal of Surgical Oncology 2002, 28:418-423.
41. Simon G., Ormel J., Von Korff M., Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry 1995, 152:352-357.
42. Stommel M., Given C.W., Given B.A. The cost of cancer home care to families. Cancer 1993, 71:1867-1874.